New Interfellmin Lactobacillus Brevis Labre Nano

This product is a plant-derived lactic acid bacteria - the nano-sized lactobacillus brevis. This product is formulated with 18 billion units of lactobacillus brevis per recommended daily intake. Lactobacillus brevis ("Labre") is a lactic acid bacterium that was discovered in "Suguki pickles" from Kyoto. It works by increasing the body's ability to produce interferon, and by stimulating the activity of cells such as NK cells that are involved in immunity. It has also been confirmed to significantly reduce the intestinal "age" and rejuvenate the intestine. The nano-sized Labre produces interferons at the rate 5.5 times that of the regular-sized Labre. We have at last made it possible to shrink the plant-derived lactic acid bacteria Labre down to a nano-scale. Lactic acid bacteria, like collagen, are large in size and are not easily absorbed. When solidifying products such as regular supplements, the size of one bacterium or molecule becomes bigger than necessary. However, just because it is bigger, doesn't mean the effect is magnified. On the contrary, it may not absorb well, or reach every corner of the digestive system. Labre, which is a component in the new Interfellmin, has been solidified to 1 billionth of its previous size by the latest biotechnology methods that extract, culture, and concentrate only Labre. This significant achievement is a result of the company's many years of research. This product also adds:

• Butrytic acid bacteria (Clostridium butyricum M-II588)
• Bifidobacterium longum BR-108